Becton Dickinson Inventory 2010-2024 | BDX

Becton Dickinson inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
  • Becton Dickinson inventory for the quarter ending September 30, 2024 was $3.255B, a 9.28% decline year-over-year.
  • Becton Dickinson inventory for 2023 was $3.273B, a 1.52% increase from 2022.
  • Becton Dickinson inventory for 2022 was $3.224B, a 17.54% increase from 2021.
  • Becton Dickinson inventory for 2021 was $2.743B, a 0% decline from 2020.
Becton Dickinson Annual Inventory
(Millions of US $)
2023 $3,273
2022 $3,224
2021 $2,743
2020 $2,743
2019 $2,579
2018 $2,451
2017 $1,818
2016 $1,719
2015 $1,959
2014 $1,495
2013 $1,402
2012 $1,241
2011 $1,245
2010 $1,145
2009 $1,157
Becton Dickinson Quarterly Inventory
(Millions of US $)
2024-06-30 $3,255
2024-03-31 $3,229
2023-12-31 $3,304
2023-09-30 $3,273
2023-06-30 $3,588
2023-03-31 $3,656
2022-12-31 $3,604
2022-09-30 $3,224
2022-06-30 $3,163
2022-03-31 $3,258
2021-12-31 $3,035
2021-09-30 $2,743
2021-06-30 $2,947
2021-03-31 $2,895
2020-12-31 $2,814
2020-09-30 $2,743
2020-06-30 $2,945
2020-03-31 $2,793
2019-12-31 $2,760
2019-09-30 $2,579
2019-06-30 $2,629
2019-03-31 $2,627
2018-12-31 $2,522
2018-09-30 $2,451
2018-06-30 $2,562
2018-03-31 $2,543
2017-12-31 $2,967
2017-09-30 $1,818
2017-06-30 $1,829
2017-03-31 $1,747
2016-12-31 $1,692
2016-09-30 $1,719
2016-06-30 $1,835
2016-03-31 $1,846
2015-12-31 $1,985
2015-09-30 $1,959
2015-06-30 $2,020
2015-03-31 $2,278
2014-12-31 $1,512
2014-09-30 $1,495
2014-06-30 $1,553
2014-03-31 $1,512
2013-12-31 $1,467
2013-09-30 $1,402
2013-06-30 $1,409
2013-03-31 $1,392
2012-12-31 $1,360
2012-09-30 $1,241
2012-06-30 $1,239
2012-03-31 $1,321
2011-12-31 $1,262
2011-09-30 $1,245
2011-06-30 $1,331
2011-03-31 $1,277
2010-12-31 $1,195
2010-09-30 $1,145
2010-06-30 $1,122
2010-03-31 $1,166
2009-12-31 $1,164
2009-09-30 $1,157
2009-06-30 $1,207
2009-03-31 $1,181
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.352B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36